Kenneth L. Davis

Davis is President and Chief Executive Officer of the Mount Sinai Health System in New York City, an American author and medical researcher who developed the Alzheimer's Disease Assessment Scale, the most widely used tool to test the efficacy of treatments for Alzheimer's Disease designed specifically to evaluate the severity of cognitive and noncognitive behavioral dysfunctions characteristic to persons with Alzheimer's disease.

In 1979, Davis was made Chief of Psychiatry at Bronx Veteran's Affairs Medical Center, where he became the first director of its Schizophrenia Biological Research Center. From 1987 until 2003, he was Chairman of Psychiatry at Mount Sinai School of Medicine.

In 2003, Davis was appointed Dean of Mount Sinai School of Medicine and held that position until 2007, when he was succeeded by Dennis S. Charney, M.D. Davis was also appointed as the President and C.E.O. of Mount Sinai Medical Center in 2003 – positions he holds today. In 2015, Davis had gross compensation from the Icahn School of Medicine at Mount Sinai of $4,147,755. He is the director of the Mount Sinai Silvio Conte Neuroscience Center, Trustee of the New York Academy of Medicine, Trustee of the Aspen Institute